RedHill Biopharma (RDHL) Capital Expenditures (2012 - 2022)
RedHill Biopharma (RDHL) posted quarterly Capital Expenditures of -$22000.0 for Q3 2022, down 4.76% year-over-year from -$23100.0 in Q3 2021, and up 86.5% quarter-over-quarter from -$163000.0 in Q2 2022.
RedHill Biopharma (RDHL) Capital Expenditures (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Capital Expenditures for 11 consecutive years, with -$22000.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Capital Expenditures fell 4.76% year-over-year to -$22000.0; the TTM figure through Dec 2022 stood at -$198000.0 (down 72.17% YoY), while the FY2025 annual figure was -$5000.0, up 44.44% from the prior year.
- Capital Expenditures improved to -$22000.0 in Q3 2022 per RDHL's latest filing, from -$163000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at -$1000.0 in Q3 2019 and bottomed at -$242000.0 in Q1 2020.
- Historically, Capital Expenditures has averaged -$51631.6 across 5 years, with a median of -$20000.0 in 2020.
- Annual changes were most pronounced in 2018 — Capital Expenditures jumped 98.04% — and 2020, when it slumped 16500.0%.
- RedHill Biopharma's Capital Expenditures stood at -$5000.0 in 2018, then slumped by 560.0% to -$33000.0 in 2019, then tumbled by 48.48% to -$49000.0 in 2020, then jumped by 93.88% to -$3000.0 in 2021, then sank by 633.33% to -$22000.0 in 2022.
- Business Quant data shows RDHL's Capital Expenditures at -$22000.0 in Q3 2022, -$163000.0 in Q2 2022, and -$13000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -22,000.00 |
| Sep 30, 2022 | -22,000.00 |
| Jun 30, 2022 | -163,000.00 |
| Jun 30, 2022 | -163,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Sep 30, 2021 | -21,000.00 |
| Sep 30, 2021 | -21,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Mar 31, 2021 | -88,000.00 |
| Mar 31, 2021 | -88,000.00 |
| Dec 31, 2020 | -49,000.00 |
| Dec 31, 2020 | -49,000.00 |
| Sep 30, 2020 | -166,000.00 |
| Sep 30, 2020 | -166,000.00 |
| Jun 30, 2020 | -20,000.00 |
| Jun 30, 2020 | -20,000.00 |